data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Soligenix
(NASDAQ:SNGX)
$0.5719
-0.0089[-1.53%]
Last update: 1:36PM
Day High/Low0.55 - 0.58
52 Week High/Low0.38 - 1.32
Open / Close0.58 / -
Float / Outstanding42.9M / 43.1M
Vol / Avg.107.1K / 168.9K
Mkt Cap24.6M
P/E-
50d Avg. Price0.54
Div / Yield-
Payout Ratio-
EPS-0.11
Total Float42.9M

Soligenix (NASDAQ:SNGX), Quotes and News Summary

Soligenix (NASDAQ: SNGX)

Day High/Low0.55 - 0.58
52 Week High/Low0.38 - 1.32
Open / Close0.58 / -
Float / Outstanding42.9M / 43.1M
Vol / Avg.107.1K / 168.9K
Mkt Cap24.6M
P/E-
50d Avg. Price0.54
Div / Yield-
Payout Ratio-
EPS-0.11
Total Float42.9M
Benzinga - 3 days ago
Benzinga - Jun 28, 2022, 10:07AM
Benzinga - Jun 28, 2022, 7:33AM
Benzinga - Jun 27, 2022, 10:02AM
Benzinga - Jun 23, 2022, 7:32AM
Benzinga - May 24, 2022, 10:41AM
Benzinga - May 23, 2022, 7:34AM
Benzinga - May 19, 2022, 2:03PM
Benzinga - May 19, 2022, 11:02AM
Benzinga - Apr 19, 2022, 7:41AM
Benzinga - Mar 29, 2022, 7:34AM
Benzinga - Mar 17, 2022, 9:35AM
Benzinga - Mar 17, 2022, 7:34AM
Benzinga - Jan 13, 2022, 3:18PM
Benzinga - Jan 12, 2022, 12:01PM
Benzinga - Jan 10, 2022, 7:46AM
Benzinga - Jan 4, 2022, 8:56AM
Benzinga - Jan 4, 2022, 7:31AM
Benzinga - Dec 23, 2021, 4:08PM
Benzinga - Dec 15, 2021, 7:57AM
Benzinga - Dec 2, 2021, 7:34AM
Sector: Health Care.Industry: Biotechnology
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-12
REV
Q1 2022Est.ActualSurprise
EPS-0.070-0.100 -0.0300
REV188.063K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Soligenix Questions & Answers

Q
How do I buy Soligenix (SNGX) stock?
A

You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Soligenix's (SNGX) competitors?
Q
What is the target price for Soligenix (SNGX) stock?
A

The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 599.42% upside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Soligenix (SNGX)?
A

The stock price for Soligenix (NASDAQ: SNGX) is $0.5719 last updated Today at July 5, 2022, 5:36 PM UTC.

Q
Does Soligenix (SNGX) pay a dividend?
A

There are no upcoming dividends for Soligenix.

Q
When is Soligenix (NASDAQ:SNGX) reporting earnings?
A

Soligenix’s Q2 earnings are confirmed for Friday, August 12, 2022.

Q
Is Soligenix (SNGX) going to split?
A

There is no upcoming split for Soligenix.

Q
What sector and industry does Soligenix (SNGX) operate in?
A

Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.